Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)
Stopped early
Conditions studied: Brain Cancer, Prostate Cancer, Lung Cancer
In brief
The purpose of this study is the development of noninvasive (having no direct contact) detector and electronic system that will directly measure tumor blood flow rate.
Key facts
- Study ID
- NCT01987193
- Run by
- University of Florida
- People needed
- 3
- Starts
- 2012-07-01
- Expected to finish
- 2018-05-01
- Last updated by the study team
- 2018-05-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Solid tumors in the intracranial, thoracic, or pelvic regions.
- Exclusion Criteria: N/A
Where it is running
- University of Florida Proton Therapy Institute — Jacksonville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.